| abstract |
The invention provides the use of a Serine Protease Inhibitor (SPI) in combination with an antioxidant, to achieve an improved and synergistic effect on the healing of wounds, especially chronic wounds, such as pressure sores or leg ulcers. The invention also includes the use of antioxidants as stabilizing entities during the production, transport, storage and sterilisation of compositions, such as pharmaceutical compositions or medical devices, containing oxidatively sensitive active pharmaceutical entities, such as SPI's. |